ABIO logo

ARCA Biopharma (ABIO) Selling, General & Administrative Expenses

ABIO Annual SG&A

$6.28 M
+$436.00 K+7.46%

31 December 2023

ABIO Selling, General & Administrative Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABIO Quarterly SG&A

$2.99 M
+$675.00 K+29.13%

30 June 2024

ABIO Quarterly SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABIO TTM SG&A

-$760.57 M
-$7.20 M-0.96%

30 June 2024

ABIO TTM SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABIO Selling, General & Administrative Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.5%+93.9%-10000.0%
3 y3 years+31.6%+134.1%-10000.0%
5 y5 years+62.0%+134.1%-10000.0%

ABIO Selling, General & Administrative Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time-79.5%-70.7%-2582.6%

ARCA Biopharma Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
June 2024
-
$2.99 M(+29.1%)
$8.47 M(+17.7%)
Mar 2024
-
$2.32 M(+50.2%)
$7.19 M(+14.5%)
Dec 2023
$6.28 M(+7.5%)
$1.54 M(-4.5%)
$6.28 M(+0.9%)
Sept 2023
-
$1.61 M(-6.1%)
$6.23 M(+1.4%)
June 2023
-
$1.72 M(+22.3%)
$6.14 M(-0.2%)
Mar 2023
-
$1.41 M(-5.4%)
$6.16 M(+5.3%)
Dec 2022
$5.85 M(+6.3%)
$1.49 M(-2.7%)
$5.85 M(-4.1%)
Sept 2022
-
$1.53 M(-11.9%)
$6.10 M(+4.3%)
June 2022
-
$1.73 M(+57.9%)
$5.85 M(+8.8%)
Mar 2022
-
$1.10 M(-36.9%)
$5.38 M(-2.3%)
Dec 2021
$5.50 M(+15.3%)
$1.74 M(+36.1%)
$5.50 M(-3.2%)
Sept 2021
-
$1.28 M(+1.4%)
$5.69 M(+6.3%)
June 2021
-
$1.26 M(+2.8%)
$5.35 M(+6.4%)
Mar 2021
-
$1.23 M(-36.2%)
$5.03 M(+5.3%)
Dec 2020
$4.77 M(+19.9%)
$1.92 M(+104.7%)
$4.77 M(+27.4%)
Sept 2020
-
$939.00 K(+0.1%)
$3.75 M(+1.1%)
June 2020
-
$938.00 K(-3.8%)
$3.71 M(-3.4%)
Mar 2020
-
$975.00 K(+9.1%)
$3.84 M(-3.6%)
Dec 2019
$3.98 M(+2.6%)
$894.00 K(-0.7%)
$3.98 M(-0.2%)
Sept 2019
-
$900.00 K(-15.7%)
$3.99 M(-0.5%)
June 2019
-
$1.07 M(-4.6%)
$4.01 M(+1.7%)
Mar 2019
-
$1.12 M(+24.1%)
$3.94 M(+1.7%)
Dec 2018
$3.88 M(-16.3%)
$902.00 K(-2.2%)
$3.88 M(-12.6%)
Sept 2018
-
$922.00 K(-8.0%)
$4.44 M(-1.4%)
June 2018
-
$1.00 M(-4.8%)
$4.50 M(-1.1%)
Mar 2018
-
$1.05 M(-28.0%)
$4.55 M(-1.8%)
Dec 2017
$4.64 M(+8.7%)
$1.46 M(+48.2%)
$4.64 M(+6.7%)
Sept 2017
-
$987.00 K(-6.1%)
$4.34 M(-0.1%)
June 2017
-
$1.05 M(-7.4%)
$4.35 M(+0.5%)
Mar 2017
-
$1.14 M(-3.1%)
$4.33 M(+1.4%)
Dec 2016
$4.26 M(-2.9%)
$1.17 M(+18.0%)
$4.26 M(-2.5%)
Sept 2016
-
$992.00 K(-3.5%)
$4.38 M(-2.4%)
June 2016
-
$1.03 M(-4.3%)
$4.49 M(+1.3%)
Mar 2016
-
$1.07 M(-16.2%)
$4.43 M(+0.8%)
Dec 2015
$4.39 M(+8.0%)
$1.28 M(+16.4%)
$4.39 M(+6.1%)
Sept 2015
-
$1.10 M(+13.3%)
$4.14 M(+3.8%)
June 2015
-
$972.00 K(-6.3%)
$3.99 M(-0.8%)
Mar 2015
-
$1.04 M(+0.7%)
$4.02 M(-1.1%)
Dec 2014
$4.07 M(+1.4%)
$1.03 M(+8.4%)
$4.07 M(-3.1%)
Sept 2014
-
$950.00 K(-5.6%)
$4.20 M(-1.4%)
June 2014
-
$1.01 M(-7.0%)
$4.26 M(+1.3%)
Mar 2014
-
$1.08 M(-6.7%)
$4.21 M(+4.8%)
Dec 2013
$4.01 M(+24.3%)
$1.16 M(+14.7%)
$4.01 M(+14.6%)
Sept 2013
-
$1.01 M(+6.2%)
$3.50 M(+7.3%)
June 2013
-
$952.00 K(+7.1%)
$3.26 M(+4.1%)
Mar 2013
-
$889.00 K(+37.2%)
$3.13 M(-2.9%)
Dec 2012
$3.23 M(-36.0%)
$648.00 K(-16.1%)
$3.23 M(-10.8%)
Sept 2012
-
$772.00 K(-6.2%)
$3.62 M(-12.5%)
June 2012
-
$823.00 K(-16.4%)
$4.13 M(-8.5%)
Mar 2012
-
$984.00 K(-5.3%)
$4.52 M(-10.5%)
Dec 2011
$5.05 M(-16.9%)
$1.04 M(-19.3%)
$5.05 M(-8.2%)
Sept 2011
-
$1.29 M(+6.7%)
$5.50 M(-1.6%)
June 2011
-
$1.21 M(-20.2%)
$5.59 M(-6.1%)
Mar 2011
-
$1.51 M(+1.3%)
$5.95 M(-1.9%)
Dec 2010
$6.07 M
$1.49 M(+8.1%)
$6.07 M(-2.5%)
DateAnnualQuarterlyTTM
Sept 2010
-
$1.38 M(-12.0%)
$6.22 M(-9.2%)
June 2010
-
$1.57 M(-3.6%)
$6.85 M(-25.1%)
Mar 2010
-
$1.63 M(-1.2%)
$9.14 M(-28.8%)
Dec 2009
$12.84 M(+51.6%)
$1.65 M(-17.9%)
$12.84 M(+54.7%)
Sept 2009
-
$2.01 M(-48.0%)
$8.30 M(-16.9%)
June 2009
-
$3.86 M(-27.5%)
$9.99 M(+26.9%)
Mar 2009
-
$5.32 M(-284.1%)
$7.88 M(+20.0%)
Dec 2008
$8.47 M(-59.2%)
-$2.89 M(-178.2%)
$6.56 M(-50.9%)
Sept 2008
-
$3.70 M(+111.9%)
$13.37 M(-3.6%)
June 2008
-
$1.75 M(-56.5%)
$13.88 M(-28.5%)
Mar 2008
-
$4.01 M(+2.3%)
$19.41 M(-6.5%)
Dec 2007
$20.76 M(-32.2%)
$3.92 M(-6.8%)
$20.76 M(-11.4%)
Sept 2007
-
$4.20 M(-42.2%)
$23.44 M(-9.2%)
June 2007
-
$7.27 M(+35.5%)
$25.80 M(+0.0%)
Mar 2007
-
$5.37 M(-18.7%)
$25.79 M(-15.8%)
Dec 2006
$30.63 M(+93.8%)
$6.60 M(+0.5%)
$30.64 M(+6.7%)
Sept 2006
-
$6.57 M(-9.6%)
$28.70 M(+9.1%)
June 2006
-
$7.26 M(-28.9%)
$26.31 M(+18.5%)
Mar 2006
-
$10.21 M(+118.8%)
$22.20 M(+40.5%)
Dec 2005
$15.80 M(+78.2%)
$4.67 M(+11.8%)
$15.80 M(+14.8%)
Sept 2005
-
$4.17 M(+32.5%)
$13.77 M(+12.9%)
June 2005
-
$3.15 M(-17.4%)
$12.19 M(+10.9%)
Mar 2005
-
$3.81 M(+45.0%)
$10.99 M(+23.9%)
Dec 2004
$8.87 M(-41.1%)
$2.63 M(+1.1%)
$8.87 M(+28.1%)
Sept 2004
-
$2.60 M(+33.2%)
$6.93 M(-3.6%)
June 2004
-
$1.95 M(+15.6%)
$7.19 M(-44.3%)
Mar 2004
-
$1.69 M(+146.6%)
$12.91 M(-14.3%)
Dec 2003
$15.07 M(+0.6%)
$685.00 K(-76.1%)
$15.07 M(-25.6%)
Sept 2003
-
$2.86 M(-62.7%)
$20.26 M(-0.1%)
June 2003
-
$7.67 M(+99.5%)
$20.28 M(+28.6%)
Mar 2003
-
$3.85 M(-34.6%)
$15.77 M(+5.3%)
Dec 2002
$14.98 M(+11.4%)
$5.88 M(+104.2%)
$14.98 M(+17.5%)
Sept 2002
-
$2.88 M(-9.0%)
$12.75 M(-5.4%)
June 2002
-
$3.17 M(+3.5%)
$13.47 M(-0.3%)
Mar 2002
-
$3.06 M(-16.2%)
$13.51 M(+0.4%)
Dec 2001
$13.45 M(+44.4%)
$3.65 M(+1.2%)
$13.45 M(+13.8%)
Sept 2001
-
$3.60 M(+12.6%)
$11.82 M(+13.2%)
June 2001
-
$3.20 M(+6.6%)
$10.45 M(+7.4%)
Mar 2001
-
$3.00 M(+48.7%)
$9.73 M(+4.4%)
Dec 2000
$9.31 M(+15.0%)
$2.02 M(-9.3%)
$9.31 M(-3.9%)
Sept 2000
-
$2.23 M(-10.3%)
$9.70 M(+4.6%)
June 2000
-
$2.48 M(-4.2%)
$9.27 M(+7.9%)
Mar 2000
-
$2.59 M(+7.9%)
$8.59 M(+4.8%)
Dec 1999
$8.10 M(-14.7%)
$2.40 M(+33.3%)
$8.20 M(0.0%)
Sept 1999
-
$1.80 M(0.0%)
$8.20 M(-8.9%)
June 1999
-
$1.80 M(-18.2%)
$9.00 M(-6.3%)
Mar 1999
-
$2.20 M(-8.3%)
$9.60 M(+1.1%)
Dec 1998
$9.50 M(+93.9%)
$2.40 M(-7.7%)
$9.50 M(+5.6%)
Sept 1998
-
$2.60 M(+8.3%)
$9.00 M(+18.4%)
June 1998
-
$2.40 M(+14.3%)
$7.60 M(+26.7%)
Mar 1998
-
$2.10 M(+10.5%)
$6.00 M(+25.0%)
Dec 1997
$4.90 M(+188.2%)
$1.90 M(+58.3%)
$4.80 M(+65.5%)
Sept 1997
-
$1.20 M(+50.0%)
$2.90 M(+70.6%)
June 1997
-
$800.00 K(-11.1%)
$1.70 M(+88.9%)
Mar 1997
-
$900.00 K
$900.00 K
Dec 1996
$1.70 M
-
-

FAQ

  • What is ARCA biopharma annual selling, general & administrative expenses?
  • What is the all time high annual SG&A for ARCA biopharma?
  • What is ARCA biopharma annual SG&A year-on-year change?
  • What is ARCA biopharma quarterly selling, general & administrative expenses?
  • What is the all time high quarterly SG&A for ARCA biopharma?
  • What is ARCA biopharma quarterly SG&A year-on-year change?
  • What is ARCA biopharma TTM selling, general & administrative expenses?
  • What is the all time high TTM SG&A for ARCA biopharma?
  • What is ARCA biopharma TTM SG&A year-on-year change?

What is ARCA biopharma annual selling, general & administrative expenses?

The current annual SG&A of ABIO is $6.28 M

What is the all time high annual SG&A for ARCA biopharma?

ARCA biopharma all-time high annual selling, general & administrative expenses is $30.63 M

What is ARCA biopharma annual SG&A year-on-year change?

Over the past year, ABIO annual selling, general & administrative expenses has changed by +$436.00 K (+7.46%)

What is ARCA biopharma quarterly selling, general & administrative expenses?

The current quarterly SG&A of ABIO is $2.99 M

What is the all time high quarterly SG&A for ARCA biopharma?

ARCA biopharma all-time high quarterly selling, general & administrative expenses is $10.21 M

What is ARCA biopharma quarterly SG&A year-on-year change?

Over the past year, ABIO quarterly selling, general & administrative expenses has changed by +$1.45 M (+93.91%)

What is ARCA biopharma TTM selling, general & administrative expenses?

The current TTM SG&A of ABIO is -$760.57 M

What is the all time high TTM SG&A for ARCA biopharma?

ARCA biopharma all-time high TTM selling, general & administrative expenses is $30.64 M

What is ARCA biopharma TTM SG&A year-on-year change?

Over the past year, ABIO TTM selling, general & administrative expenses has changed by -$766.85 M (-12205.22%)